Norovirus Infections

Infectious Disease·MeSH: Caliciviridae Infections

8 drugs in development·1 company·4 clinical trials

Drug Pipeline by Phase

Phase 2(3)

Drug	Company
bivalent norovirus vaccine candidate	Vaxart, Inc. (VXRT)
investigational oral vaccine candidate for covid-19	Vaxart, Inc. (VXRT)
seasonal influenza vaccine candidate	Vaxart, Inc. (VXRT)

Phase 1(2)

Drug	Company
vxa g1.1 nn-t	Vaxart, Inc. (VXRT)
vxa g2.4 ns-t	Vaxart, Inc. (VXRT)

Phase 1/Phase 2(3)

Drug	Company
norovirus gi.1 norwalk virus inoculum	Vaxart, Inc. (VXRT)
vxa-g1.1-nn	Vaxart, Inc. (VXRT)
vxa-g2.4-ns	Vaxart, Inc. (VXRT)

BioSniper tracks 8 drugs in development for Norovirus Infections across 1 company.

There are 4 clinical trials targeting Norovirus Infections tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.